Keller, Karsten
Sinning, Christoph
Schulz, Andreas
Jünger, Claus
Schmitt, Volker H.
Hahad, Omar
Zeller, Tanja
Beutel, Manfred
Pfeiffer, Norbert
Strauch, Konstantin
Blankenberg, Stefan
Lackner, Karl J.
Prochaska, Jürgen H.
Schulz, Eberhard
Münzel, Thomas
Wild, Philipp S.
Funding for this research was provided by:
Federal Ministry of Education and Research (BMBF 01EO1503)
DIASyM research core (BMBF 161L0217A)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 7 August 2021
Accepted: 28 October 2021
First Online: 18 November 2021
Competing interests
: J.H.P. received funding for lecturing by Bayer AG and Boehringer Ingelheim outside the topic of this work. P.S.W. reports the submitted work grants from Bayer AG, non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting and lecturing fees from Bayer Health Care, grants from Daiichi Sankyo Europe, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from I.E.M., outside the submitted work. All other authors declare no disclosures that could be perceived as conflict of interest in the context of the present work.